Azmasol Bexicap (DPI)

Azmasol Bexicap (DPI) Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Azmasol Bexicap (DPI) is a brand name. Its generic name is Salbutamol.

Introduction

Azmasol Bexicap (DPI), also known as albuterol, is a short-acting bronchodilator medication, and is widely used to treat and prevent wheezing due to asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. It works by helping open the airways in the lungs to make breathing easier. It can also be used to prevent exercise-induced bronchospasm.

Uses

Azmasol Bexicap (DPI) medications are used to treat and prevent asthma and other similar respiratory problems like wheezing, shortness of breath and chest tightness. Inhaled Azmasol Bexicap (DPI) can also be used to prevent exercise-induced bronchospasm. Azmasol Bexicap (DPI) is sometimes also used to relieve severe chest tightness in people with COPD and to treat breathing problems in very premature babies.

Mechanism of Action

Azmasol Bexicap (DPI) works by stimulating the Beta2 receptors of the lungs, which relaxes the smooth muscles of the airways. This allows the airways to open up and allows more air into the lungs. As a result, breathing is easier and less strained. Azmasol Bexicap (DPI) also binds to the receptors in the skin, which may cause the skin to feel cold or tingly for a short period of time.

How Long Does It Take to Work?

Azmasol Bexicap (DPI) medications typically start working within 5 minutes to reduce wheezing and shortness of breath. Maximum benefits of the medication can be felt after 15 to 30 minutes. However, it is important to note that the effects of salbutamol vary from person to person and depend on how severe the asthma or other respiratory disorder is.

Absorption

Inhaled salbutamol is rapidly absorbed into the bloodstream when inhaled through an inhaler device. The maximum concentration of salbutamol in the blood is usually reached about 15-25 minutes after administration.

Route of Elimination

Azmasol Bexicap (DPI) is mainly eliminated via metabolism in the liver and also in the kidneys. The elimination half-life of salbutamol is about 4 to 6 hours.

Dosage

Azmasol Bexicap (DPI) is recommended and available in different strengths ranging from 2mg to 8mg. The dosage should be determined based on age, weight, and other factors as recommended by the doctor. The dosage is usually taken 2 to 4 times a day. Inhaled salbutamol is usually prescribed along with other medications known as 'controller medicines' such as corticosteroids, that are used to reduce the frequency and intensity of asthma attacks.

Administration

Inhaled salbutamol medications are usually taken orally or by inhalation using an inhaler or a nebulizer machine, depending on the patient's condition and severity of the disease. The inhaler or the nebulizer machine must be used properly to ensure that the medicine is delivered directly to the lungs.

Side Effects

Common side effects of salbutamol include tremor (shaking), headache, dry mouth, throat irritation, nausea, increased heart rate, palpitations, and dizziness.

Toxicity

Overdoses of Azmasol Bexicap (DPI) can lead to high blood potassium levels and heart rhythm disturbances. High doses or prolonged use can also cause serious side effects such as seizures or muscle weakness.

Precaution

Patients should always inform the physician about any health problems they have, such as heart disease, high blood pressure or diabetes, in order to avoid the risk of adverse drug reactions. Also, salbutamol should be used with caution in pregnant women or those who are breastfeeding.

Interactions

Azmasol Bexicap (DPI) is known to interact with certain other medications such as diuretics, MAO inhibitors, beta blockers, ACE inhibitors, calcium channel blockers, and some antibiotics. So, it is important to inform your doctor about all your medications before using salbutamol.

Disease Interaction

Azmasol Bexicap (DPI) is known to interact with certain diseases such as diabetes, hyperthyroidism, heart disease, renal and hepatic impairment, and mucoid impaction.

Drug Interaction

Azmasol Bexicap (DPI) is known to interact with certain drugs such as diuretics, MAO inhibitors, beta blockers, ACE inhibitors, calcium channel blockers, and some antibiotics.

Food Interactions

There are no known significant food interactions with Azmasol Bexicap (DPI). However, it is recommended to limit or avoid caffeine while taking Azmasol Bexicap (DPI) medications.

Pregnancy Use

Azmasol Bexicap (DPI) is not recommended for use in pregnant women. It is recommended to avoid using Azmasol Bexicap (DPI) during pregnancy, as it may cause serious harm to an unborn baby.

Lactation Use

It is generally recommended to avoid using Azmasol Bexicap (DPI) in breastfeeding mothers, as it is not known if it can pass into breast milk. It is advisable to consult a physician before using Azmasol Bexicap (DPI) in breastfeeding mothers.

Acute Overdose

The signs and symptoms of an acute overdose of Azmasol Bexicap (DPI) include chest pain, tremors, rapid heartbeat, headache, nausea, vomiting, dizziness, and seizures. If any of these symptoms occur after taking Azmasol Bexicap (DPI), contact a healthcare professional immediately.

Contraindication

Azmasol Bexicap (DPI) is contraindicated in people with hypersensitivity or allergy to its active ingredients, hypersensitivity to sympathomimetic amines, tachyarrhythmia, and coronary insufficiency.

Use Direction

The dosage and use of salbutamol should always be determined after consulting a doctor or a healthcare professional. Proper instructions should be followed while using an inhaler or nebulizer device.

Storage Condition

Azmasol Bexicap (DPI) inhalers or nebulizer solutions should be stored at room temperature, away from direct heat and light.

Volume of Distribution

The volume of distribution of salbutamol depends on the route of administration. After intravenous administration, the volume of distribution is 1L/kg.

Half Life

The half-life of salbutamol is approximately 4-6 hours after administration.

Clearance

The clearance of salbutamol after oral administration is approximately 120 mL/min/kg.

Here you find in details version of Azmasol Bexicap (DPI)

Some Frequently Asked Questions About Azmasol Bexicap (DPI)

Azmasol Bexicap (DPI), also known as albuterol or Ventolin, is a bronchodilator drug used primarily to relieve symptoms of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscle of the airways, widening them and allowing more air to flow through.

Azmasol Bexicap (DPI) works by stimulating beta-2 receptors located on the smooth muscle of the bronchial tubes. This stimulation causes an increase in intracellular levels of Cyclic AMP, which results in an increased force of bronchial contraction. This increased force helps to open the airways and among other effects, increases the speed with which air can move through the respiratory tract.

The most common symptoms of COPD include shortness of breath, a chronic cough, difficulty breathing, wheezing, and a productive sputum. Other symptoms may include chest tightness, pain and fatigue.

Yes, Azmasol Bexicap (DPI) is used to treat the symptoms of COPD, including shortness of breath, a chronic cough, difficulty breathing, wheezing, chest tightness, and a productive sputum.

Common side effects of Azmasol Bexicap (DPI) include headache, nausea, dizziness, shakiness, nervousness, irritability, increased heart rate, and a dry or sore throat. If any of these effects become severe or worsen, contact your doctor or pharmacist.

The effects of Azmasol Bexicap (DPI) are usually felt within minutes and can last up to 6 hours, depending on the dose.

Yes, Azmasol Bexicap (DPI) is generally considered safe for pregnant women. However, as with any medication, be sure to consult your doctor before taking it.

The usual dose for adults and children 4 years of age and older is 2-4 puffs (by inhalation) every 4-6 hours, up to a maximum of 8 puffs per day. For children under 4 years of age, it is recommended to consult a doctor.

No, Azmasol Bexicap (DPI) is not believed to be addictive. However, it is important to take the medication as prescribed by your doctor.

Yes, Azmasol Bexicap (DPI) is commonly used to treat the symptoms of asthma, including shortness of breath, wheezing, coughing, and chest tightness. It is important to take the medication as prescribed by your doctor.

No, Azmasol Bexicap (DPI) is not typically used to treat allergies. Allergy medications should be prescribed by your doctor.

It is not recommended to use Azmasol Bexicap (DPI) in infants without first consulting your doctor. Azmasol Bexicap (DPI) is not approved for use in infants younger than 4 years of age.

Azmasol Bexicap (DPI) is usually taken by inhalation using an inhaler or a nebulizer. Your doctor can show you how to use your inhaler or nebulizer correctly.

Yes, Azmasol Bexicap (DPI) is the same medication as albuterol.

No, Azmasol Bexicap (DPI) is a prescription medication and is not available over the counter.

Yes, there are several other medications that can be used to treat the symptoms of asthma or COPD, such as ipratropium, formoterol, and budesonide. Your doctor can help you decide which medication is best for you.

There is no difference between Azmasol Bexicap (DPI) and Ventolin, they are both brand names for the same medication.

Yes, Azmasol Bexicap (DPI) is available in an inhaler form.

Yes, it is generally safe to take Azmasol Bexicap (DPI) with other medications. However, it is important to talk to your doctor or pharmacist first to make sure the medications you are taking are safe to use together.

If you are taking Azmasol Bexicap (DPI) for asthma or COPD, you should notice that your breathing is easier and that your wheezing and coughing are reduced. If you do not experience any of these effects, please consult your doctor.

Yes, it is generally safe to take Azmasol Bexicap (DPI) while breastfeeding. However, it is important to talk to your doctor or pharmacist first to make sure the medication is safe for you and your baby.

Azmasol Bexicap (DPI) should be stored at room temperature, away from moisture, direct sunlight, and heat. Make sure to keep the inhaler tightly closed when not in use.

Azmasol Bexicap (DPI) is a bronchodilator drug and ipratropium is an anticholinergic drug. Both medications are used to treat the symptoms of asthma and COPD, but their mechanisms of action are different. Azmasol Bexicap (DPI) works by stimulating the beta-2 receptors of the smooth muscle, while ipratropium works by blocking the action of acetylcholine on bronchial smooth muscle.

Yes, Azmasol Bexicap (DPI) can be used for other purposes not listed in this medication guide. Talk to your doctor about the possible uses of this drug.

Yes, Azmasol Bexicap (DPI) may interact with other medications, including over-the-counter drugs, vitamins, and herbal supplements. Be sure to talk to your doctor or pharmacist before taking any other medications or supplements while taking Azmasol Bexicap (DPI).

The effects of Azmasol Bexicap (DPI) are usually felt within minutes and can last up to 6 hours, depending on the dose.

The usual dose for adults and children 4 years of age and older is 2-4 puffs (by inhalation) every 4-6 hours, up to a maximum of 8 puffs per day. For children under 4 years of age, it is recommended to consult a doctor.

It is not recommended to take an extra dose of Azmasol Bexicap (DPI) without first consulting your doctor. Overdosing on Azmasol Bexicap (DPI) can cause serious side effects and should only be done under medical supervision.

It is generally recommended to take Azmasol Bexicap (DPI) before exercise, as this will help to prevent exercise-induced asthma. However, it is important to consult your doctor to ensure you are taking the right dose and taking the medication at the right time.

If you miss a dose of Azmasol Bexicap (DPI), take it as soon as you remember. If it is close to your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for the missed one.

Long-term use of Azmasol Bexicap (DPI) may cause an increased heartbeat and restlessness. If you experience any of these side effects, contact your doctor.

Yes, you can fly while taking Azmasol Bexicap (DPI), provided you take the appropriate precautions for flying with a medical condition. It is recommended to check with your airline for any special instructions or restrictions.

Azmasol Bexicap (DPI) is a bronchodilator drug and Fluticasone is a corticosteroid drug. Both medications are used to treat the symptoms of asthma and COPD, but their mechanisms of action are different. Azmasol Bexicap (DPI) works by stimulating the beta-2 receptors of the smooth muscle, while Fluticasone works by reducing inflammation and swelling of the airways.

Possible signs of an allergic reaction to Azmasol Bexicap (DPI) include hives, difficulty breathing, swelling of the face, lips, tongue, or throat. If you experience any of these symptoms, stop taking the medication and seek medical help immediately.

Yes, it is generally safe to take an antihistamine while taking Azmasol Bexicap (DPI). However, it is important to talk to your doctor or pharmacist first to make sure the medications you are taking are safe to use together.

Yes, alcohol can interact with Azmasol Bexicap (DPI) and may increase the risk of side effects. Avoid drinking alcohol while taking Azmasol Bexicap (DPI) and consult your doctor if you have any questions or concerns.

If you forget to take your dose of Azmasol Bexicap (DPI), take it as soon as you remember. If it is close to your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for the missed one.